4.5 Article

Weak protein-protein interactions revealed by immiscible filtration assisted by surface tension

Journal

ANALYTICAL BIOCHEMISTRY
Volume 447, Issue -, Pages 133-140

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ab.2013.10.038

Keywords

Immunoprecipitation; Polyol-responsive; Green fluorescent protein; Low-density lipoprotein receptor; Glycogen synthase kinase-3 beta; Exclusion-based sample preparation

Funding

  1. UW Stem Cell and Regenerative Medicine Center
  2. Walter H. Coulter Translational Research Partnership
  3. NIH [5R33CA137673, 5R01CA077474, 5R01GM083681]
  4. Bill & Melinda Gates Foundation through the Grand Challenges in Global Health initiative

Ask authors/readers for more resources

Biological mechanisms are often mediated by transient interactions between multiple proteins. The isolation of intact protein complexes is essential to understanding biochemical processes and an important prerequisite for identifying new drug targets and biomarkers. However, low-affinity interactions are often difficult to detect. Here, we use a newly described method called immiscible filtration assisted by surface tension (IFAST) to isolate proteins under defined binding conditions. This method, which gives a near-instantaneous isolation, enables significantly higher recovery of transient complexes compared to current wash-based protocols, which require reequilibration at each of several wash steps, resulting in protein loss. The method moves proteins, or protein complexes, captured on a solid phase through one or more immiscible-phase barriers that efficiently exclude the passage of nonspecific material in a single operation. We use a previously described polyol-responsive monoclonal antibody to investigate the potential of this new method to study protein binding. In addition, difficult-to-isolate complexes involving the biologically and clinically important Wnt signaling pathway were isolated. We anticipate that this simple, rapid method to isolate intact, transient complexes will enable the discoveries of new signaling pathways, biomarkers, and drug targets. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available